title: Painless acute pancreatitis associated with sorafenib treatment: a case report.
authors.affiliation: Department of Urology, Sumitomo Hospital, Kita-ku, Osaka, 530-0005, Japan. yasukoba1216@gmail.com
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Kanemitu
authors.forename: Akihito
authors.initials: A
authors.lastname: Kamoto
authors.forename: Mototaka
authors.initials: M
authors.lastname: Satoh
authors.forename: Naoki
authors.initials: N
authors.lastname: Mori
authors.forename: Kenichiro
authors.initials: K
authors.lastname: Sekii
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Yoshioka
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Itatani
authors.forename: Takashi
authors.initials: T
authors.lastname: Fujimoto
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000009:adverse effects* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010195:Pancreatitis / Q000139:chemically induced*; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D007155:Immunologic Factors; D016898:Interferon-alpha; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib